All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Garlic Tablets Outperform Antibiotic Metronidazole in Treating Bacterial Vaginosis, Study Finds

By

Sayer Ji

20h ago· 13 min readenNews

Summary

A randomized controlled trial has found that garlic tablets outperformed the antibiotic metronidazole in treating bacterial vaginosis, achieving a 70% reduction compared to 48.3%, with significantly fewer side effects. The article contextualizes this finding within the broader crisis of antimicrobial resistance (AMR), which now kills more people than HIV/AIDS or malaria, with WHO projecting a 70% rise in AMR deaths by 2050. It also notes that metronidazole is classified as a probable human carcinogen by both the U.S. National Toxicology Program and WHO's IARC, while garlic's active compound allicin showed potent antimicrobial activity.

Source

Twitter / XGarlic Tablets Outperform Antibiotic Metronidazole in Treating Bacterial Vaginosis, Study Findssayerji.substack.com

Key quotes

· 4 pulled
Antimicrobial resistance (AMR) now kills more people than HIV/AIDS or malaria, with WHO projecting a 70% rise in AMR deaths by 2050.
A randomized controlled trial (RCT) found garlic tablets achieved a 70% reduction in bacterial vaginosis vs. 48.3% for metronidazole — with significantly fewer side effects.
Metronidazole, the antibiotic garlic bested, is classified as a probable human carcinogen by both the U.S. National Toxicology Program and the WHO's IARC.
Garlic's active compound allicin inhibited 100% of 30 clinical isolates tested.
Snippet from the RSS feed
New science confirms an ancient remedy outperforms a first-line pharmaceutical — without the side effects or the superbug problem

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.